Literature DB >> 9414979

Sclerosing cholangitis, race and sex.

P Kelly1, S Patchett, D McCloskey, E Alstead, M Farthing, P Fairclough.   

Abstract

BACKGROUND: Primary sclerosing cholangitis develops in 3-10% of patients with ulcerative colitis, and may be associated with an increased cancer risk. Ulcerative colitis is probably less common in people of African origin than in populations of European descent. AIMS AND METHODS: To review the records of all patients under regular follow up for ulcerative colitis at St Bartholomew's Hospital (London, UK), a tertiary referral centre, prompted by discovering a cluster of cases with common features. RESULTS AND
CONCLUSIONS: Among 166 patients with ulcerative colitis under regular follow up, only four (all women) are of African or Caribbean genetic origin, and three of these have developed sclerosing cholangitis within three years of presentation with colitis, compared with four of 162 patients of European or Asian descent (odds ratio 119, 95% confidence interval 8-3837; p = 0.0002). This cluster, which is not explained by common HLA DR or DQ type, suggests that Africans and Afro-Caribbeans, especially women, may be at increased risk of sclerosing cholangitis. This may reflect genetic influences on the development of enteric and hepatobiliary inflammatory disease.

Entities:  

Mesh:

Year:  1997        PMID: 9414979      PMCID: PMC1891575          DOI: 10.1136/gut.41.5.688

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  10 in total

Review 1.  Aetiology and natural history of primary sclerosing cholangitis--a decade of progress?

Authors:  R W Chapman
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

2.  Inflammatory bowel disease in West Indians.

Authors:  D P O'Donoghue; M L Clark
Journal:  Br Med J       Date:  1976-10-02

3.  Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.

Authors:  J A Snook; R W Chapman; K Fleming; D P Jewell
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

4.  Inflammatory bowel disease in 64 black patients: analysis of course, complications, and surgery.

Authors:  H Simsek; B M Schuman
Journal:  J Clin Gastroenterol       Date:  1989-06       Impact factor: 3.062

5.  Ulcerative colitis in a developing country of Africa: the Baragwanath experience of the first 46 patients.

Authors:  I Segal
Journal:  Int J Colorectal Dis       Date:  1988-11       Impact factor: 2.571

6.  HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis.

Authors:  W Z Mehal; Y M Lo; B P Wordsworth; J M Neuberger; S C Hubscher; K A Fleming; R W Chapman
Journal:  Gastroenterology       Date:  1994-01       Impact factor: 22.682

Review 7.  Primary sclerosing cholangitis.

Authors:  Y M Lee; M M Kaplan
Journal:  N Engl J Med       Date:  1995-04-06       Impact factor: 91.245

8.  Incidence rates of ulcerative colitis and Crohn's disease in fifteen areas of the United States.

Authors:  C F Garland; A M Lilienfeld; A I Mendeloff; J A Markowitz; K B Terrell; F C Garland
Journal:  Gastroenterology       Date:  1981-12       Impact factor: 22.682

9.  Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis.

Authors:  T A Brentnall; R C Haggitt; P S Rabinovitch; M B Kimmey; M P Bronner; D S Levine; K V Kowdley; A C Stevens; D A Crispin; M Emond; C E Rubin
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

10.  Ulcerative colitis in West Indian immigrants.

Authors:  G F Benfield; P Asquith
Journal:  Q J Med       Date:  1986-05
  10 in total
  3 in total

Review 1.  Extraintestinal manifestations of inflammatory bowel disease.

Authors:  C N Bernstein
Journal:  Curr Gastroenterol Rep       Date:  2001-12

2.  Molecular screening of patients with long standing extensive ulcerative colitis: detection of p53 and Ki-ras mutations by single strand conformation polymorphism analysis and differential hybridisation in colonic lavage fluid.

Authors:  S M Lang; D F Stratakis; M Heinzlmann; W Heldwein; B Wiebecke; K Loeschke
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

3.  The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population.

Authors:  Elaine Toy; Sripriya Balasubramanian; Carlo Selmi; Chin-Shang Li; Christopher L Bowlus
Journal:  BMC Gastroenterol       Date:  2011-07-18       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.